Results 281 to 290 of about 204,436 (364)

A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry

ESC Heart Failure, Volume 12, Issue 4, Page 3114-3133, August 2025.
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner, Sebastian König, Anne Nitsche, Sven Hohenstein, Jana Nagel, Melchior Seyfarth, Henning Baberg, Alexander Lauten, Hans Neuser, Alexander Staudt, Jürgen Tebbenjohanns, René Andrié, Michael Niehaus, Markus W. Ferrari, Ralf Kuhlen, Andreas Bollmann   +15 more
wiley   +1 more source

21. Cardiac Resynchronization Therapy: Implanting & Clinical Aspects [PDF]

, 2005
Stefano Bianchi, Maurizio Lunati, F. Sgreccia, A Lucifero, Amélia Feliciano, Carlo Peraldo, Marco Cardinale, Natale Di Belardino, G. Fradusco, A Puglisi   +9 more
openalex   +1 more source

Recent Advances in Cardiac Resynchronization Therapy: Current Treatment and Future Direction. [PDF]

J Clin Med
Siddiqui A, Tasouli-Drakou V, Ringor M, DiCaro MV, Yee B, Lei K, Tak T.   +6 more
europepmc   +1 more source

630 Evaluation of diastolic function in cardiac resynchronization therapy

, 2005
Manuela Bocchino, Luigi Sciarra, E Moro, Elena Marras, César Marcon, R. Delise   +5 more
openalex   +1 more source

Early occurrence of heart failure hospitalization or ventricular arrhythmia re‐define the long‐term prognosis after CRT

ESC Heart Failure, Volume 12, Issue 4, Page 2780-2790, August 2025.
Abstract Aims Classifying patients as responders or non‐responders to cardiac resynchronization therapy (CRT) has been recently challenged, suggesting that preventing heart failure (HF) progression may also provide survival benefits. We assessed a novel classification based on echocardiographic left ventricular (LV) reverse remodelling and the ...
Anna Zsofia Toth, Laszlo Nagy, Krisztina Maria Szabo, Vivien Racz, Alexandra Kiss, Gabor Sandorfi, Attila Borbely, Tibor Laszlo Nagy, Zoltan Csanadi   +8 more
wiley   +1 more source

Application and Research of Left Bundle Branch-Optimized Cardiac Resynchronization Therapy in Ischemic Cardiomyopathy. [PDF]

Rev Cardiovasc Med
Zhang D, Lang M, Prakash Earnest BS, Ali Abdou IEM.   +3 more
europepmc   +1 more source

Plasma volume status predicting clinical outcomes in patients undergoing transcatheter edge‐to‐edge mitral valve repair

ESC Heart Failure, Volume 12, Issue 4, Page 2855-2865, August 2025.
Abstract Aims Plasma volume status (PVS) is recognized as a marker of systemic congestion, but its clinical utility in patients with mitral regurgitation (MR) undergoing transcatheter edge‐to‐edge mitral valve repair (M‐TEER) has not been well established. This study aimed to evaluate the prognostic significance of PVS in these patients.
Ai Kagase, Masanori Yamamoto, Takahiro Tokuda, Ryotaku Kawahata, Hiroto Nishio, Tetsuro Shimura, Ryo Yamaguchi, Mitsuru Sago, Yuki Izumi, Mike Saji, Masahiko Asami, Yusuke Enta, Masaki Nakashima, Shinichi Shirai, Masaki Izumo, Shingo Mizuno, Yusuke Watanabe, Makoto Amaki, Kazuhisa Kodama, Junichi Yamaguchi, Toru Naganuma, Hiroki Bouta, Yohei Ohno, Masahiro Yamawaki, Hiroshi Ueno, Kazuki Mizutani, Daisuke Hachinohe, Toshiaki Otsuka, Shunsuke Kubo, Kentaro Hayashida, OCEAN‐Mitral Investigators   +30 more
wiley   +1 more source

Reply to the use of tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy. [PDF]

Europace
Liew A, Howell S, Rinaldi CA.
europepmc   +1 more source

Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

, 2014
Brown, MW, Cannom, DS, Dan, A, Daubert, JP, Estes, NAM, Foster, E, Ghanem, A, Goldenberg, I, Greenberg, H, Kautzner, J, Klein, HU, Klempfner, R, Kuniss, M, Kutyifa, V, McNitt, S, Merkely, B, Moss, AJ, Pfeffer, MA, Polonsky, B, Quesada, A, Solomon, SD, Viskin, S, Wilber, D, Zareba, W   +23 more
core   +1 more source